Summit Tx Capital, L.P. Edgewise Therapeutics, Inc. Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q1 2025
A detailed history of Summit Tx Capital, L.P. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 9,664 shares of EWTX stock, worth $143,027. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,664Holding current value
$143,027% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding EWTX
# of Institutions
220Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$222 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$132 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$96.9 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$91.1 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$89 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $935M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...